Table 2 Diabetes in relation to hepatocellular carcinoma (HCC) in total subjects, males and females separately, and by duration of diabetes prior to baseline interivew, Singapore Chinese Health Study 1993–2010
Total number N (%) | HCC cases | HR (95% CI) a | HR (95% CI) b | |
|---|---|---|---|---|
All | ||||
Non-diabetics | 55 852 (91.1) | 412 | 1.00 | 1.00 |
Diabetics | 5469 (8.9) | 87 | 2.64 (2.09–3.33) | 2.14 (1.69–2.71) |
Men | ||||
Non-diabetics | 24 933 (91.4) | 303 | 1.00 | 1.00 |
Diabetics | 2360 (8.6) | 58 | 2.51 (1.89–3.32) | 2.11 (1.58–2.81) |
Women | ||||
Non-diabetics | 30 919 (90.9) | 109 | 1.00 | 1.00 |
Diabetics | 3109 (9.1) | 29 | 3.27 (2.17–4.92) | 2.14 (1.41–3.25) |
Number of years of diabetes diagnosed prior to baseline interview | ||||
Non-diabetics | 55 852 (91.1) | 412 | 1.00 | 1.00 |
<5 years | 2139 (3.5) | 39 | 2.80 (2.01–3.89) | 2.41 (1.73–3.35) |
5–10 years | 1341 (2.2) | 21 | 2.53 (1.63–3.92) | 2.14 (1.38–3.33) |
⩾10 years | 1989 (3.2) | 27 | 2.52 (1.7–3.71) | 1.84 (1.24–2.72) |
